Benoit J. Van Den Eynde

Brussels Branch
Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

Journal: bioRxiv : the preprint server for biology

Published: June 29, 2026

Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF.

Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF.

Journal: Science immunology

Published: April 03, 2026

Adrenergic regulation of cancer immunity.

Adrenergic regulation of cancer immunity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 08, 2025

Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells.

Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells.

Journal: Immunology and cell biology

Published: April 24, 2025

Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.

Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.

Journal: Journal for immunotherapy of cancer

Published: September 08, 2024

IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti-PD-1 Therapy in Tumor-Bearing Mice.

IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti-PD-1 Therapy in Tumor-Bearing Mice.

Journal: Cancer immunology research

Published: August 28, 2024

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells.

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells.

Journal: Nature communications

Published: October 12, 2023

Editorial: Heme proteins: key players in the regulation of immune responses.

Editorial: Heme proteins: key players in the regulation of immune responses.

Journal: Frontiers in immunology

Published: July 19, 2023

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.

Journal: Journal for immunotherapy of cancer

Published: May 12, 2023

Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Journal: Science translational medicine

Published: April 12, 2023

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.

Journal: Journal for immunotherapy of cancer

Published: March 30, 2023

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression.

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression.

Journal: Cell reports

Published: December 04, 2022

Showing 1-12 of 102

Last Updated: 09/26/2026